Compare GIB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIB | ICLR |
|---|---|---|
| Founded | 1976 | 1990 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.1B |
| IPO Year | 1999 | 2001 |
| Metric | GIB | ICLR |
|---|---|---|
| Price | $81.97 | $195.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 18 |
| Target Price | $86.09 | ★ $231.29 |
| AVG Volume (30 Days) | 412.8K | ★ 1.2M |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.80 | N/A |
| Revenue Next Year | $2.74 | $4.60 |
| P/E Ratio | $13.59 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $66.57 |
| 52 Week High | $95.20 | $219.04 |
| Indicator | GIB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 63.05 | 53.47 |
| Support Level | $68.57 | $157.92 |
| Resistance Level | $82.35 | $219.04 |
| Average True Range (ATR) | 2.08 | 8.19 |
| MACD | -0.26 | -1.38 |
| Stochastic Oscillator | 67.66 | 37.02 |
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.